David Melnick

2019

In 2019, David Melnick earned a total compensation of $936.3K as Chief Medical Officer at Spero Therapeutics, a 43% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$156,000
Option Awards$271,837
Salary$389,167
Stock Awards$118,493
Other$792
Total$936,288

Melnick received $389.2K in salary, accounting for 42% of the total pay in 2019.

Melnick also received $156K in non-equity incentive plan, $271.8K in option awards, $118.5K in stock awards and $792 in other compensation.

Rankings

In 2019, David Melnick's compensation ranked 9,575th out of 13,971 executives tracked by ExecPay. In other words, Melnick earned more than 31.5% of executives.

ClassificationRankingPercentile
All
9,575
out of 13,971
32nd
Division
Manufacturing
3,850
out of 5,698
32nd
Major group
Chemicals And Allied Products
1,463
out of 2,197
33rd
Industry group
Drugs
1,250
out of 1,883
34th
Industry
Pharmaceutical Preparations
928
out of 1,395
34th
Source: SEC filing on September 30, 2020.

Melnick's colleagues

We found two more compensation records of executives who worked with David Melnick at Spero Therapeutics in 2019.

2019

Ankit Mahadevia

Spero Therapeutics

Chief Executive Officer

2019

Christina Larkin

Spero Therapeutics

Chief Operating Officer

News

You may also like